Loading…
Healthcare costs attributable to e-cigarette use and subsequent uptake of cigarette smoking by Australians who have never smoked
Objective. New legislation to curb the rapid increase in e-cigarette use among youth is underway. We estimated the future healthcare costs for chronic diseases from e-cigarette use among never smokers who transition to tobacco smoking. Methods. Using populationattributable fractions, we estimated th...
Saved in:
Published in: | Australian health review 2024-02, Vol.48 (1), p.52-57 |
---|---|
Main Authors: | , |
Format: | Article |
Language: | English |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | |
---|---|
cites | |
container_end_page | 57 |
container_issue | 1 |
container_start_page | 52 |
container_title | Australian health review |
container_volume | 48 |
creator | Gordon, Louisa G. Preston, Paige |
description | Objective. New legislation to curb the rapid increase in e-cigarette use among youth is underway. We estimated the future healthcare costs for chronic diseases from e-cigarette use among never smokers who transition to tobacco smoking. Methods. Using populationattributable fractions, we estimated the health expenditure attributable to e-cigarettes based on the prevalence of e-cigarette use, uptake of tobacco smoking, and risk of smoking on developing chronic disease. Data for men and women were derived from published reports on e-cigarette use prevalence, risk of smoking-related disease and addiction, and health expenditure for 25 diseases. Sensitivity analyses were undertaken to address data input variation. Results. Future healthcare costs attributed to new e-cigarette-initiated smokers were conservatively estimated to be (in Australian dollars) $179.6 million annually. Collectively, the estimated costs were highest for respiratory diseases ($102.2 million; 57% of total costs), malignant cancers ($49.6 million; 28%), and cardiovascular disease ($27.7 million; 15%). The uptake rate of e-cigarettes was more important in driving healthcare costs than the proportion moving from e-cigarettes to cigarette smoking. Conclusion. High avoidable health system costs are predicted for the treatment of chronic conditions created by e-cigarette-initiated smoking. These costs exclude the immediate and direct healthcare harms of e-cigarette-related poisoning, lung injury, and respiratory problems, and costs associated with the unknown health harms of e-cigarette use alone. The proposed regulations to curb recreational e-cigarette use in Australia are set to prevent expensive health care arising sometime in the future from new cigarette smokers. |
doi_str_mv | 10.1071/AH23178 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_2929145758</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2929145758</sourcerecordid><originalsourceid>FETCH-LOGICAL-c271t-41410c1f7635ef2b163f418ee596336b23bac8e659787848adcc00f24e4edc113</originalsourceid><addsrcrecordid>eNpFkDFPwzAUhC0EEqUg_oIlBqaAX2zHzlhVQJEqscAcOc5LkzaNi-0UdeOnE2glphvu093pCLkF9gBMweNskXJQ-oxMQIg80bkQ52TCQGaJVFpfkqsQ1oxBLnU2Id8LNF1srPFIrQsxUBOjb8shmrJDGh3FxLar0Y4R6RCQmr6iYSgDfg7YRzrsotkgdTX9x8LWbdp-RcsDnQ0hetO1pg_0q3G0MXukPe7R_1FYXZOL2nQBb046JR_PT-_zRbJ8e3mdz5aJTRXERIAAZqFWGZdYpyVkvBagEWWecZ6VKS-N1ZjJXGmlhTaVtYzVqUCBlQXgU3J3zN15Ny4PsVi7wfdjZZHmaQ5CKqlH6v5IWe9C8FgXO99ujT8UwIrfe4vTvfwHXzVuKA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2929145758</pqid></control><display><type>article</type><title>Healthcare costs attributable to e-cigarette use and subsequent uptake of cigarette smoking by Australians who have never smoked</title><source>ABI/INFORM Global</source><creator>Gordon, Louisa G. ; Preston, Paige</creator><creatorcontrib>Gordon, Louisa G. ; Preston, Paige</creatorcontrib><description>Objective. New legislation to curb the rapid increase in e-cigarette use among youth is underway. We estimated the future healthcare costs for chronic diseases from e-cigarette use among never smokers who transition to tobacco smoking. Methods. Using populationattributable fractions, we estimated the health expenditure attributable to e-cigarettes based on the prevalence of e-cigarette use, uptake of tobacco smoking, and risk of smoking on developing chronic disease. Data for men and women were derived from published reports on e-cigarette use prevalence, risk of smoking-related disease and addiction, and health expenditure for 25 diseases. Sensitivity analyses were undertaken to address data input variation. Results. Future healthcare costs attributed to new e-cigarette-initiated smokers were conservatively estimated to be (in Australian dollars) $179.6 million annually. Collectively, the estimated costs were highest for respiratory diseases ($102.2 million; 57% of total costs), malignant cancers ($49.6 million; 28%), and cardiovascular disease ($27.7 million; 15%). The uptake rate of e-cigarettes was more important in driving healthcare costs than the proportion moving from e-cigarettes to cigarette smoking. Conclusion. High avoidable health system costs are predicted for the treatment of chronic conditions created by e-cigarette-initiated smoking. These costs exclude the immediate and direct healthcare harms of e-cigarette-related poisoning, lung injury, and respiratory problems, and costs associated with the unknown health harms of e-cigarette use alone. The proposed regulations to curb recreational e-cigarette use in Australia are set to prevent expensive health care arising sometime in the future from new cigarette smokers.</description><identifier>ISSN: 0156-5788</identifier><identifier>EISSN: 1449-8944</identifier><identifier>DOI: 10.1071/AH23178</identifier><language>eng</language><publisher>Collingwood: CSIRO</publisher><subject>Chemicals ; Chronic illnesses ; Costs ; Disease ; Electronic cigarettes ; Health care expenditures ; Legislation ; Nicotine ; Poisoning ; Poisons ; Public health ; Smoking cessation ; Tobacco ; Toxicity ; Trends ; Vaping ; Womens health</subject><ispartof>Australian health review, 2024-02, Vol.48 (1), p.52-57</ispartof><rights>Copyright CSIRO Feb 2024</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><orcidid>0000-0002-3159-4249</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2929145758/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$H</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2929145758?pq-origsite=primo$$EHTML$$P50$$Gproquest$$H</linktohtml><link.rule.ids>314,780,784,11688,27924,27925,36060,44363,74895</link.rule.ids></links><search><creatorcontrib>Gordon, Louisa G.</creatorcontrib><creatorcontrib>Preston, Paige</creatorcontrib><title>Healthcare costs attributable to e-cigarette use and subsequent uptake of cigarette smoking by Australians who have never smoked</title><title>Australian health review</title><description>Objective. New legislation to curb the rapid increase in e-cigarette use among youth is underway. We estimated the future healthcare costs for chronic diseases from e-cigarette use among never smokers who transition to tobacco smoking. Methods. Using populationattributable fractions, we estimated the health expenditure attributable to e-cigarettes based on the prevalence of e-cigarette use, uptake of tobacco smoking, and risk of smoking on developing chronic disease. Data for men and women were derived from published reports on e-cigarette use prevalence, risk of smoking-related disease and addiction, and health expenditure for 25 diseases. Sensitivity analyses were undertaken to address data input variation. Results. Future healthcare costs attributed to new e-cigarette-initiated smokers were conservatively estimated to be (in Australian dollars) $179.6 million annually. Collectively, the estimated costs were highest for respiratory diseases ($102.2 million; 57% of total costs), malignant cancers ($49.6 million; 28%), and cardiovascular disease ($27.7 million; 15%). The uptake rate of e-cigarettes was more important in driving healthcare costs than the proportion moving from e-cigarettes to cigarette smoking. Conclusion. High avoidable health system costs are predicted for the treatment of chronic conditions created by e-cigarette-initiated smoking. These costs exclude the immediate and direct healthcare harms of e-cigarette-related poisoning, lung injury, and respiratory problems, and costs associated with the unknown health harms of e-cigarette use alone. The proposed regulations to curb recreational e-cigarette use in Australia are set to prevent expensive health care arising sometime in the future from new cigarette smokers.</description><subject>Chemicals</subject><subject>Chronic illnesses</subject><subject>Costs</subject><subject>Disease</subject><subject>Electronic cigarettes</subject><subject>Health care expenditures</subject><subject>Legislation</subject><subject>Nicotine</subject><subject>Poisoning</subject><subject>Poisons</subject><subject>Public health</subject><subject>Smoking cessation</subject><subject>Tobacco</subject><subject>Toxicity</subject><subject>Trends</subject><subject>Vaping</subject><subject>Womens health</subject><issn>0156-5788</issn><issn>1449-8944</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>M0C</sourceid><recordid>eNpFkDFPwzAUhC0EEqUg_oIlBqaAX2zHzlhVQJEqscAcOc5LkzaNi-0UdeOnE2glphvu093pCLkF9gBMweNskXJQ-oxMQIg80bkQ52TCQGaJVFpfkqsQ1oxBLnU2Id8LNF1srPFIrQsxUBOjb8shmrJDGh3FxLar0Y4R6RCQmr6iYSgDfg7YRzrsotkgdTX9x8LWbdp-RcsDnQ0hetO1pg_0q3G0MXukPe7R_1FYXZOL2nQBb046JR_PT-_zRbJ8e3mdz5aJTRXERIAAZqFWGZdYpyVkvBagEWWecZ6VKS-N1ZjJXGmlhTaVtYzVqUCBlQXgU3J3zN15Ny4PsVi7wfdjZZHmaQ5CKqlH6v5IWe9C8FgXO99ujT8UwIrfe4vTvfwHXzVuKA</recordid><startdate>202402</startdate><enddate>202402</enddate><creator>Gordon, Louisa G.</creator><creator>Preston, Paige</creator><general>CSIRO</general><scope>AAYXX</scope><scope>CITATION</scope><scope>0U~</scope><scope>1-H</scope><scope>3V.</scope><scope>4T-</scope><scope>4U-</scope><scope>7RO</scope><scope>7RV</scope><scope>7WY</scope><scope>7WZ</scope><scope>7X7</scope><scope>7XB</scope><scope>87Z</scope><scope>88C</scope><scope>88E</scope><scope>8AI</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8FL</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AXJJW</scope><scope>AYAGU</scope><scope>BENPR</scope><scope>BEZIV</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FREBS</scope><scope>FRNLG</scope><scope>FYUFA</scope><scope>F~G</scope><scope>GHDGH</scope><scope>K60</scope><scope>K6~</scope><scope>K9.</scope><scope>KB0</scope><scope>L.-</scope><scope>L.0</scope><scope>M0C</scope><scope>M0S</scope><scope>M0T</scope><scope>M1P</scope><scope>NAPCQ</scope><scope>PQBIZ</scope><scope>PQBZA</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><orcidid>https://orcid.org/0000-0002-3159-4249</orcidid></search><sort><creationdate>202402</creationdate><title>Healthcare costs attributable to e-cigarette use and subsequent uptake of cigarette smoking by Australians who have never smoked</title><author>Gordon, Louisa G. ; Preston, Paige</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c271t-41410c1f7635ef2b163f418ee596336b23bac8e659787848adcc00f24e4edc113</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Chemicals</topic><topic>Chronic illnesses</topic><topic>Costs</topic><topic>Disease</topic><topic>Electronic cigarettes</topic><topic>Health care expenditures</topic><topic>Legislation</topic><topic>Nicotine</topic><topic>Poisoning</topic><topic>Poisons</topic><topic>Public health</topic><topic>Smoking cessation</topic><topic>Tobacco</topic><topic>Toxicity</topic><topic>Trends</topic><topic>Vaping</topic><topic>Womens health</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Gordon, Louisa G.</creatorcontrib><creatorcontrib>Preston, Paige</creatorcontrib><collection>CrossRef</collection><collection>Global News & ABI/Inform Professional</collection><collection>Trade PRO</collection><collection>ProQuest Central (Corporate)</collection><collection>Docstoc</collection><collection>University Readers</collection><collection>Asian Business Database</collection><collection>ProQuest Nursing and Allied Health Journals</collection><collection>ABI/INFORM Collection</collection><collection>ABI/INFORM Global (PDF only)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>ABI/INFORM Global (Alumni Edition)</collection><collection>Healthcare Administration Database (Alumni)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Asian Business Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ABI/INFORM Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>Asian & European Business Collection</collection><collection>Australia & New Zealand Database</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>Business Premium Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Asian & European Business Collection (Alumni)</collection><collection>Business Premium Collection (Alumni)</collection><collection>Health Research Premium Collection</collection><collection>ABI/INFORM Global (Corporate)</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Business Collection (Alumni Edition)</collection><collection>ProQuest Business Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>ABI/INFORM Professional Advanced</collection><collection>ABI/INFORM Professional Standard</collection><collection>ABI/INFORM Global</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Healthcare Administration Database</collection><collection>Medical Database</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Business</collection><collection>ProQuest One Business (Alumni)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><jtitle>Australian health review</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Gordon, Louisa G.</au><au>Preston, Paige</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Healthcare costs attributable to e-cigarette use and subsequent uptake of cigarette smoking by Australians who have never smoked</atitle><jtitle>Australian health review</jtitle><date>2024-02</date><risdate>2024</risdate><volume>48</volume><issue>1</issue><spage>52</spage><epage>57</epage><pages>52-57</pages><issn>0156-5788</issn><eissn>1449-8944</eissn><abstract>Objective. New legislation to curb the rapid increase in e-cigarette use among youth is underway. We estimated the future healthcare costs for chronic diseases from e-cigarette use among never smokers who transition to tobacco smoking. Methods. Using populationattributable fractions, we estimated the health expenditure attributable to e-cigarettes based on the prevalence of e-cigarette use, uptake of tobacco smoking, and risk of smoking on developing chronic disease. Data for men and women were derived from published reports on e-cigarette use prevalence, risk of smoking-related disease and addiction, and health expenditure for 25 diseases. Sensitivity analyses were undertaken to address data input variation. Results. Future healthcare costs attributed to new e-cigarette-initiated smokers were conservatively estimated to be (in Australian dollars) $179.6 million annually. Collectively, the estimated costs were highest for respiratory diseases ($102.2 million; 57% of total costs), malignant cancers ($49.6 million; 28%), and cardiovascular disease ($27.7 million; 15%). The uptake rate of e-cigarettes was more important in driving healthcare costs than the proportion moving from e-cigarettes to cigarette smoking. Conclusion. High avoidable health system costs are predicted for the treatment of chronic conditions created by e-cigarette-initiated smoking. These costs exclude the immediate and direct healthcare harms of e-cigarette-related poisoning, lung injury, and respiratory problems, and costs associated with the unknown health harms of e-cigarette use alone. The proposed regulations to curb recreational e-cigarette use in Australia are set to prevent expensive health care arising sometime in the future from new cigarette smokers.</abstract><cop>Collingwood</cop><pub>CSIRO</pub><doi>10.1071/AH23178</doi><tpages>6</tpages><orcidid>https://orcid.org/0000-0002-3159-4249</orcidid></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0156-5788 |
ispartof | Australian health review, 2024-02, Vol.48 (1), p.52-57 |
issn | 0156-5788 1449-8944 |
language | eng |
recordid | cdi_proquest_journals_2929145758 |
source | ABI/INFORM Global |
subjects | Chemicals Chronic illnesses Costs Disease Electronic cigarettes Health care expenditures Legislation Nicotine Poisoning Poisons Public health Smoking cessation Tobacco Toxicity Trends Vaping Womens health |
title | Healthcare costs attributable to e-cigarette use and subsequent uptake of cigarette smoking by Australians who have never smoked |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T21%3A31%3A41IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Healthcare%20costs%20attributable%20to%20e-cigarette%20use%20and%20subsequent%20uptake%20of%20cigarette%20smoking%20by%20Australians%20who%20have%20never%20smoked&rft.jtitle=Australian%20health%20review&rft.au=Gordon,%20Louisa%20G.&rft.date=2024-02&rft.volume=48&rft.issue=1&rft.spage=52&rft.epage=57&rft.pages=52-57&rft.issn=0156-5788&rft.eissn=1449-8944&rft_id=info:doi/10.1071/AH23178&rft_dat=%3Cproquest_cross%3E2929145758%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c271t-41410c1f7635ef2b163f418ee596336b23bac8e659787848adcc00f24e4edc113%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2929145758&rft_id=info:pmid/&rfr_iscdi=true |